Skip to main content
. Author manuscript; available in PMC: 2016 May 20.
Published in final edited form as: Neuron. 2015 Apr 30;86(4):1029–1040. doi: 10.1016/j.neuron.2015.03.063

Figure 1. VU0409551 is a potent mGlu5 PAM in HEK293A-mGlu5 rat cells and native systems.

Figure 1

(A) Representative raw calcium traces following the addition of 30 μM VU0409551 and the subsequent additions of EC20 and EC80 concentrations of glutamate. (B) VU0409551 potentiates an EC20 concentration of glutamate with a potency of 235 nM in mGlu5-expressing R10A rat cells (C) VU0409551 shifts the glutamate concentration response curve with a maximum fold shift of 11 at 30 μM (D) VU0409551 did not shift the agonist concentration response curve in mGlu1,2,3,4,6,7,8-expressing cells, displaying its high selectivity for mGlu5. (E) VU0409551 potentiates glutamate-stimulated ERK1/2 phosphorylation and exhibits robust agonist activity in this assay. (F) VU0409551 potentiates glutamate-induced calcium mobilization in rat cortical astrocytes with a potency of 317 nM and maximum glutamate response of 79.5%, which is blocked by addition of 10 μM of the mGlu5 antagonist MPEP. Data represent mean ± S.E.M. from 2-4 independent experiments performed in duplicate or triplicate.

HHS Vulnerability Disclosure